pharma · Non-transfusion-dependent Thalassemia · Advanced Solid Tumors · SLN
Silence Therapeutics
Silence Therapeutics plc
Silence Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
London, GB HQ
1999 Founded
91 Employees
Public company Type
SLN · NYSE Ticker
Company details
- Status
- Public
- HQ
- London, GB
- Founded
- 1999
- Employees
- 91
- Programs
- 8
- Drugs
- 6
- Patents
- 3
Silence Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Silence Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Silence Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Silence Therapeutics.
-
SLN124-001 — Phase 1
Clinical update -
SLN124 — Phase 1
Clinical update -
Atu027 & gemcitabine in lead in safety period — Phase 2
Clinical update -
SLN124 — Phase 2
Clinical update -
SLN360 — Phase 2
Clinical update -
Atu027 — Phase 1
Clinical update -
SLN124 — Phase 1
Clinical update -
SLN360 — Phase 1
Clinical update